欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Apoptosis-Ferroptosis-ACXT-3102
ACXT-3102

Chemical Structure : ACXT-3102

CAS No.: 1816276-51-3

ACXT-3102 (SW V-49, ACXT3102)

货号: PC-28285Not For Human Use, Lab Use Only.

ACXT-3102 (SW V-49) is a cancer-specific drug conjugate and ferroptosis inducer consisting of a pro-apoptotic sigma-2 ligand as a delivery moiety (SV119), linked to an inhibitor of the cystine antiporter xCT (des-methyl Erastin, dm-Erastin), exhibits potent, targeted therapeutic for pancreatic cancer cells.

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

ACXT-3102 (SW V-49) is a cancer-specific drug conjugate and ferroptosis inducer consisting of a pro-apoptotic sigma-2 ligand as a delivery moiety (SV119), linked to an inhibitor of the cystine antiporter xCT/SLC7A11 (des-methyl Erastin, dm-Erastin), exhibits potent, targeted therapeutic for pancreatic cancer cells.
SW V-49 overcomes the chemotherapeutic plateau of dm-Erastin via enhanced drug uptake
shows potent cytotoxic response effect against PANC-1 cells with IC50 of 4.1 uM, 17-fold more effective than an equimolar mix of SV119 and dm-Erastin.
SW V-49 inhibits cell viability of multiple human pancreatic cancer organoid cultures with IC50 of 1.84 uM.
SW V-49 reduces tumor growth and improves survival in syngeneic and patient-derived xenograft models of pancreatic cancer.
SW V-49 competes for the sigma-2 receptor with known sigma-2 binders and activates cargo-specific signaling pathways.

物理化学性质&存储条件

分子量 914.14
分子式 C53H67N7O7
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(1R,3r,5S)-9-(6-((4-(2-(4-((3-(2-ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-2-oxoethoxy)benzyl)amino)hexyl)-9-azabicyclo[3.3.1]nonan-3-yl (2-methoxy-5-methylphenyl)carbamate

参考文献

1. Kerri A Ohman, et al. Oncotarget. 2016 Jun 7;7(23):33529-41.

2. Brashears CB, et al. Clin Cancer Res. 2022 Aug 15;28(16):3573-3589.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: